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ABSTRACT 
Although the advance in disease-modifying drugs has helped to stabilize the multiple sclerosis (MS) 
course increasing life-expectancy, physical deterioration still supervenes over time in most MS 
patients. In this context, physical exercise programs are considered a safe and well-tolerated tool to 
preserve functional independence in this population, which not only provides similar fitness 
improvements as usually observed in healthy general population, but it may also ameliorate some 
of the symptoms that this pathology entails (as fatigue, balance deficits, muscle weakness, etc.). 
Nowadays, the question is if exercise only aids to reverse physical deconditioning associated to the 
disease or it has the potential to have an impact on MS progression. In the present overview, the 
role of exercise as complementary therapy for modulating various physiopathological pathways 
related to MS disease such as inflammation and the neurotrophic support for neuronal survival was 
revised. Specifically, the exercise ability to modulate the immune system behaviour regulating the 
pro- and anti-inflammatory cytokine balance, as well as, to promote neuroprotective and 
neurorestorative mechanisms through the brain-derived neurotrophic factor stimulation was 
analysed. 
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¿PUEDE EL EJERCICIO FÍSICO EJERCER  
UNA FUNCIÓN NEUROPROTECTORA  
EN LA ESCLEROSIS MÚLTIPLE?  
UNA BREVE REVISIÓN DE LOS EFECTOS 
POTENCIALES DEL ENTRENAMIENTO FÍSICO  
SOBRE LAS CITOQUINAS Y EL FACTOR 
NEUROTRÓFICO DERIVADO DEL CEREBRO 
 
RESUMEN 
Aunque los avances farmacológicos han ayudado a estabilizar la evolución de la esclerosis múltiple 
(EM), aumentando notablemente la expectativa de vida, la mayoría de los pacientes con EM aún 
sufren un deterioro físico progresivo. En este contexto, los programas de ejercicio físico se 
consideran una herramienta segura que permite preservar la independencia funcional en esta 
población, proporcionando no solo las mejoras en la condición física que se observan en la 
población general, sino que también parecen eficaces para reducir la sintomatología asociada a la 
EM (como fatiga, déficit de equilibrio, debilidad muscular, etc.). Una de las preguntas actuales que 
existe en el ámbito científico es si el ejercicio físico sólo permite mejorar los síntomas y revertir el 
desacondicionamiento físico asociado con la EM o si también tiene el potencial de modular la 
progresión de la enfermedad. En la presente revisión se ofrece una perspectiva general del posible 
papel que puede jugar el ejercicio físico, como terapia complementaria en la regulación de varias 
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vías fisiopatológicas relacionadas con la EM, tales como la inflamación y el soporte neurotrófico 
para la supervivencia neuronal.  
Específicamente, se analizó la capacidad que tiene el ejercicio físico para modular el 
comportamiento del sistema inmunitario a través de la regulación del equilibrio de citoquinas pro y 
anti-inflamatorias, así como para promover mecanismos neuroprotectores a través de la 
estimulación del factor neurotrófico derivado del cerebro. 
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INTRODUCTION 
Multiple sclerosis (MS) is an immune-mediated chronic disease of the 
central nervous system (CNS) characterized by a breakdown of the blood-brain 
barrier (BBB), multifocal inflammation, demyelination, oligodendrocyte loss, 
reactive gliosis, and axonal degeneration (Baecher-Allan, Kaskow, & Weiner, 
2018; Craig, Young, Ennis, Baker, & Boggild, 2003; Hohlfeld, 1997). MS 
neurodegeneration entails several physical symptoms such as balance 
disorders, muscular weakness, spasticity and fatigue (Gandhi, Laroni, & Weiner, 
2010). Nowadays, MS is the most common neurological condition and it is 
among the most common causes of neurological disability in young adults in 
developed countries (Koch-Henriksen & Sorensen, 2010), with a much higher 
incidence (i.e. 3:1 ratio) among women (Orton et al., 2006). In Spain, its 
prevalence in the last 40 years has grown, affecting over 100 patients/100.000 
people (Fernandez et al., 2012). Although the precise aetiology of the disease is 
unclear, the immune dysregulation seems to be prompted by an interaction 
between environmental and genetic factors (Hohlfeld, 1997; Koch-Henriksen & 
Sorensen, 2010). In individuals with a genetic predisposition to develop 
autoimmunity, MS is probably triggered by an environmental antigen (i.e. viral 
or bacterial infection), which auto-reactive T cells (Th1 and Th17), in a process 
identified as molecular mimicry, targets myelin antigens in the CNS (Garg & 
Smith, 2015; O'Connor, Bar-Or, & Hafler, 2001). The different 
pathophysiological mechanisms of the disease contribute to a brain volume loss, 
which seems to be accelerated in patients with MS [annual rate: 0.5–1.35% per 
year in patients with relapsing-remitting MS (RRMS)] compared to the healthy 
general population (annual rate: 0.1%–0.3%) (Calabrese et al., 2007; De 
Stefano et al., 2014; De Stefano et al., 2010; Hardmeier et al., 2005; Narayana et 
al., 2012; Rudick, Fisher, Lee, Simon, & Jacobs, 1999; Simon, 2006). Brain 
atrophy is a prominent feature of MS that advances inexorably throughout the 
disease course, with a rate that seems to be mostly independent of the MS 
subtype (De Stefano et al., 2014; De Stefano et al., 2010). 
Although the improvement in disease-modifying drugs has helped to 
stabilize the disease progression increasing life-expectancy (Scalfari et al., 
2013), physical deterioration still ensues over time in most MS patients 
(Filippini et al., 2013). In this context, rehabilitation programs become a key 
tool to preserve functional independence and quality of life (Dalgas, 2011). 
Among different complementary therapies, exercise, understood as a planned, 
structured and repetitive physical activity undertaken over a prolonged period 
(Caspersen, Powell, & Christenson, 1985), has shown to promote relevant, not 
only physical but also psychological and cognitive, improvements in MS 
patients (Aidar et al., 2018; Pilutti, Greenlee, Motl, Nickrent, & Petruzzello, 2013; 
Platta, Ensari, Motl, & Pilutti, 2016). Years ago, MS individuals were advised not 
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to perform any vigorous physical activity because it could worsen their 
neurological status (Giesser, 2015; Sutherland & Andersen, 2001). This is 
known as Uhthoff's phenomenon, in which some MS individuals show symptom 
exacerbations such as balance perturbations and increased spasticity when 
they become overheated during exercises (Dalgas, 2011; Giesser, 2015; Opara, 
Brola, Wylegala, & Wylegala, 2016). In addition, because patients generally 
experience symptoms of fatigue, they were also advised to avoid exercise in 
order to preserve their energy for activities of daily living. Both concerns 
usually made MS individuals be less active (Motl, McAuley, & Snook, 2005; 
Nortvedt, Riise, & Maeland, 2005), fostering physical deconditioning and 
potentially creating additional comorbidities such as obesity, osteoporosis or 
vascular diseases (Giesser, 2015). Nevertheless, it has already been shown that 
physical exercise does not increase the risk of relapse or adverse events in this 
population (Giesser, 2015; Pilutti, Platta, Motl, & Latimer-Cheung, 2014); 
conversely, exercise appears to be safe, well-tolerated and not only provides 
similar health and fitness improvements as usually observed in healthy 
individuals, but it also may ameliorate some of the symptoms that this 
pathology entails such as fatigue, balance deficits, muscle weakness, etc. 
(Cruickshank, Reyes, & Ziman, 2015; Giesser, 2015; Heine, van de Port, Rietberg, 
van Wegen, & Kwakkel, 2015; Latimer-Cheung et al., 2013; Motl & Pilutti, 2012; 
Motl & Sandroff, 2015). 
An important question related to the impact of physical training in MS 
individuals' status is whether exercise only reverses physical deconditioning 
associated to the disease or it has a neuroprotective effect, which could 
attenuate the disease progression (Dalgas & Stenager, 2012). The data from the 
last decade reinforce the second approach, suggesting that physical activity 
could modulate to some extent various physiopathological pathways related to 
MS disease, like inflammation and the neurotrophic support for neuronal 
survival and regeneration. 
 
CNS inflammation in MS: the potential effect of exercise on pro- and anti-
inflammatory cytokines 
According to McDonald's criteria (Thompson et al., 2018), most MS patients 
suffer the RRMS form of the disease, which is initially characterized by relapses 
of focal neurological deficits followed by a variable degree of recovery 
(Compston & Coles, 2008). During the early stage of the RRMS, CNS 
inflammation seems to be the primary cause of damage (Loma & Heyman, 
2011). This phase is probably driven by a systemic immune response, in which 
there is a myelin-specific autoreactive lymphocyte infiltration of the BBB that 
leads to the formation of inflammatory demyelinating lesions (Ciccarelli et al., 
2014; Olsson, 1995). Cytokines are proteins that regulate the immune system 
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function (Alexander, 2002) playing an important role in the pathogenic events 
that characterize MS progression (Ozenci, Kouwenhoven, & Link, 2002). 
Commonly, in healthy individuals, due to a cross-inhibitory effect, there is a 
homeostatic balance between pro-and anti-inflammatory cytokines. In 
presence of pathogens this balance changes, resulting in an increase of pro-
inflammatory cytokines [i.e. interleukin (IL)-1, IL-6, IL-12, IL-17, IL-23 tumor 
necrosis factor (TNF)-α, interferon (INF)-γ] and a decrease of the anti-
inflammatory ones (i.e. IL-4, IL-10, IL-13) which induces, through different 
pathways, a local inflammatory and immunological response (i.e. immune cell 
differentiation, growth, proliferation and activation) (Ozenci et al., 2002). 
However, as the immune cells are sensitized to the myelin antigen in MS, the 
pro-inflammatory imbalance is self-sustained over time which induces the 
cascade of inflammatory and demyelination processes observed in the illness 
pathogenesis (Pilli, Zou, Tea, Dale, & Brilot, 2017): 1) Pro-inflammatory 
cytokines IL-12 and IL-23 participate in the peripheral immune activation 
(differentiation of CD4+ T cell into Th1 or Th17 phenotypes) regulating the 
interaction between T lymphocytes and the antigen presenting cells such as B 
cells, dendritic cells, microglia and macrophages (Loma & Heyman, 2011); 2) 
Cytokines also facilitate the migration of those activated T cells into the CNS 
disrupting the BBB through TNF-α, INFγ, IL-1β, IL-17 and IL-22 (Kebir et al., 
2007; Minagar & Alexander, 2003); 3) Once activated immune cells have 
crossed the BBB, they release several pro-inflammatory cytokines stimulating 
microglia, macrophages, astrocytes, and recruit B cells, which, in turn, damage 
myelin, oligodendrocytes and axons (Rivera-Quinones et al., 1998; Zamvil & 
Steinman, 2003). It must be noted that the release of pro-inflammatory 
cytokines such as TNF-α and INFγ promotes inflammation, also suppressing the 
differentiation of T-regulatory cells (Th2), which release anti-inflammatory 
cytokines (Minty et al., 1993; Zhu & Paul, 2008). 
Due to the role of cytokines in MS pathogenesis, the balance regulation of 
the pro- and anti-inflammatory cytokines is a major issue, not only for disease-
modifying drugs therapies (Motl et al., 2017) but for any complementary 
treatment trying to slow-down the disease progression. In this sense, as regular 
exercise has shown to chronically reduce the basal levels of inflammatory 
markers (Petersen & Pedersen, 2005), it may be expected that exercise could be 
used as an anti-inflammatory and complementary therapy in MS patients 
(Dalgas & Stenager, 2012). Physical activity seems to reduce Th1 cell 
production, but not Th2 cells production (Gleeson, 2007; Sharif et al., 2018; 
Steensberg et al., 2001), promoting a long-term immune regulation 
characterized by a post-exercise transient anti-inflammatory state (Gleeson et 
al., 2011). During and after exercise, IL-6 is released from muscles, which, in 
this case, acts as a myokine, inducing an anti-inflammatory response (Brandt & 
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Pedersen, 2010; Sharif et al., 2018). Commonly, IL-6 works together with TNF-α 
as a pro-inflammatory cytokine against a pathogen, promoting the proliferation 
and activation of Th1 cells (Sharif et al., 2018). Nevertheless, after exercise, IL-6 
is released from muscles without TNF-α secretion, working as a myokine. In 
this condition, IL-6 promotes the secretion of IL-10 and the reduction of TNF-α, 
reducing inflammation and inhibiting Th1-cells (de Vries, 1995). Conversely, IL-
6 from monocytes, which acts as a pro-inflammatory cytokine, as well as IL-2 
from Th1 lymphocytes, are inhibited during and after exercise, contributing to 
the inflammatory reduction (Lancaster et al., 2004). The decrease of Th1 
following exercise is also attributed to the increase in hormonal levels of 
cortisol and adrenaline in response to physical activity, which inhibits the 
production of IL-12 from antigen presenting cells (Elenkov & Chrousos, 1999; 
Pedersen & Hoffman-Goetz, 2000) and reduces TNF-α produced by Th1 cells 
(Bergmann et al., 1999). Although changes in circulating lymphocytes normally 
return to baseline levels in no more than 24 h (Gleeson, 2007), systematic 
changes in IL-6, cortisol and adrenaline caused by regular bouts of exercise 
could offer protection against auto-immune disease (Gleeson, 2007; Lancaster 
et al., 2004). 
While the effectiveness of regular exercise to modulate the cytokine profile 
and the progression of inflammatory-related diseases has been proven (Bilski 
et al., 2016; Leal, Lopes, & Batista, 2018; Pearson, Mungovan, & Smart, 2018; 
Pedersen, 2017), experimental studies on MS have shown limited and 
contradictory results. In a recent systematic review of the experimental studies 
conducted by Negaresh et al. (2018), no systematic cytokine changes in serum 
associated to regular exercise were found, which, according to the authors, 
would not support the idea that the cytokine modifications caused by exercise 
are a regulator of the disease progression. Nevertheless, the real effect of 
exercise on cytokine in MS must still be elucidated because, as the 
aforementioned authors pointed out, the few experimental studies present 
several methodological limitations, which hinder the generalization of the 
results: small samples, only female population, different MS types in the same 
experimental group, cytokines monitored using a variety of methods and taken 
from different body fluids, etc. For example, the fact that cytokine levels in 
plasma and serum did not change towards a more anti-inflammatory profile 
can be attributed to a lower BBB permeability caused by exercise (Mokhtarzade 
et al., 2018) which would limit the immune cell infiltration into the CNS.  
Among those limitations, from the point of view of physical exercise 
prescription, one of the most important ones that could explain the current 
disparity of cytokine findings was the high heterogeneity observed in the 
exercise programs. Acute and chronic cytokine modifications caused by 
exercise depend on several parameters as, for example, the type of exercise (i.e. 
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aerobic training, resistance training, combined training, etc.), the intensity and 
volume of training, program duration, participant training status, age, type of 
the disorder, etc. (Gleeson, 2007). For instance, focusing on the secretion of IL-6 
induced by exercise, it has been observed that the higher duration, intensity 
and greater number of muscles involved in the exercise are, the greater the 
release of this cytokine after exercise is (Gokhale, Chandrashekara, & 
Vasanthakumar, 2007; Pedersen & Febbraio, 2005). Probably, longer and more 
intense training implies higher energy demands and consequently, a greater 
carbohydrate depletion associated to a higher acute IL-6 production from 
muscles (Keller et al., 2001) which, in turn, could chronically modify pro- and 
anti-inflammatory cytokine profile. This rationale could explain why some 
studies found significant changes in the cytokine levels after training in RRMS 
individuals (Deckx et al., 2016; Golzari, Shabkhiz, Soudi, Kordi, & Hashemi, 
2010; Kierkegaard et al., 2016; Mokhtarzade, Ranjbar, Majdinasab, Patel, & 
Molanouri Shamsi, 2017). For instance, Kierkegaard et al. (2016) found a 
significant reduction in the basal level of several pro-inflammatory cytokines in 
serum in RRMS after a high-intensity resistance training performed at 80% of 
one repetition maximum test involving several muscle groups (8 exercises) 
during three months (24 sessions). Golzari et al. (2010) observed a significant 
reduction in plasma INFγ and IL-17 after a combined endurance and resistance 
training of 3 sessions per week for 2 months (24 sessions). Similarly, Deckx et 
al. (2016) found a significant reduction in plasma TNF-α when faced with 
lipopolysaccharide and IFN-𝛾𝛾 stimulation after a combined endurance and 
resistance training of 5 sessions per 2 weeks for 3 months (30 sessions). 
Overall, these findings suggest that the higher the duration, intensity and 
energy demand are, the greater the cytokine activity is. However, as individuals 
with higher fitness level show a reduced response to exercise (Gokhale et al., 
2007; Pedersen & Febbraio, 2005), a continuous and individualized modulation 
of training parameters seems to be required to elicit cytokine adaptations along 
time. In spite of these potential implications, nowadays, the small number of 
experimental studies carried out on MS, the heterogeneity of the experimental 
design and the inconsistent reporting of their training parameters hinder the 
dose-response characterization of the exercise effect on cytokines in this 
population (Negaresh et al., 2018).  
Additionally, another limitation related to the exercise program design was 
whether the training protocols were enough  to induce weight loss 
(Mokhtarzade et al., 2017; Negaresh et al., 2018), which is an important tool to 
regulate the secretion of the cytokines by the adipose tissue, i.e., adipokines 
(Gleeson et al., 2011). An important adipokine related to the MS pathology is 
leptin, which promotes the secretion of pro-inflammatory cytokines TNF-α, IL-2, 
and IL-6 and the activation of Th1 cells (Matarese, Procaccini, & De Rosa, 2008). 
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In this sense, Mokhtarzade et al. (2017) observed that weight loss in RRMS 
induced by an exercise program was significantly related with a reduction in 
leptin together with TNF-α, which, in turn, were related with greater fatigue 
improvements. These authors also observed an increase in the adiponectin 
hormone which increases the production of the anti-inflammatory cytokine IL-
10 (Kraszula et al., 2012). Although these preliminary findings suggest that 
exercise programs on MS should also focus on weight loss in order to maximize 
their effects on the cytokine and adipokine profile, further research is 
necessary to clarify the role of weight loss after training on the immune system 
in MS. 
 
CNS integrity in MS: the potential effect of exercise on brain-derived neurotrophic 
factor 
Although white matter infiltration by immune cells and subsequent 
demyelination are commonly considered the most recognizable signs of MS, 
demyelination of the cortical gray matter, axonal deterioration and CNS 
atrophy have been detected in MS patients even in early stages of the disease 
(Baecher-Allan et al., 2018; Bevan et al., 2018; Kutzelnigg et al., 2005; 
Lucchinetti et al., 2011; Siffrin, Vogt, Radbruch, Nitsch, & Zipp, 2010; Trapp & 
Nave, 2008). In MS patients, brain atrophy, mainly assessed through magnetic 
resonance imaging techniques, progresses at a faster rate than in healthy 
individuals (Vollmer et al., 2015). Importantly, neurodegenerative rather than 
demyelination processes seem to be more related with the degree of disability 
in MS (Lemus, Warrington, & Rodriguez, 2018; Wujek et al., 2002). In rodent 
models, no motor impairment has been observed in presence of demyelination 
if the axonal integrity was preserved (Rivera-Quinones et al., 1998), but long-
lasting neurological disability was found in presence of axonal loss (Wujek et al., 
2002). These findings have also been observed in MS patients, in whom the 
cortical and gray matter atrophy was the best predictor of the disease 
progression and motor disability (Fisniku et al., 2008) as well as of the degree 
of cognitive impairment (Sacco et al., 2015). In this sense, it has been suggested 
that the evolution from RRMS to a progressive form of the disease materializes 
when the CNS is not able to compensate the axonal injuries (Ksiazek-Winiarek, 
Szpakowski, & Glabinski, 2015; Nave & Trapp, 2008). This explains why there is 
a higher rate of axonal loss and brain atrophy in later stages of the disease 
(Simon, 2006). All these reasons justify that therapeutic interventions aim at 
not only reducing relapse events, inflammation and demyelination but also at 
enhancing neuroprotection and neurorestoration of the CNS (Luhder, Gold, 
Flugel, & Linker, 2013).  
A therapeutic target for preserving CNS integrity are the neurotrophins, 
which are proteins involved in neural regeneration, preservation and 
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remyelination processes (Azoulay, Vachapova, Shihman, Miler, & Karni, 2005; 
Begni, Riva, & Cattaneo, 2017; Ceni, Unsain, Zeinieh, & Barker, 2014; Ebadi et al., 
1997; Huang & Reichardt, 2001; Kelamangalath & Smith, 2013; Linker, Gold, & 
Luhder, 2009; Vacaras, Major, & Buzoianu, 2017). One of the most important 
neurotrophins is the brain-derived neurotrophic factor (BDNF) which, in 
healthy subjects, has been associated with age-related volume reduction in 
white matter (Driscoll et al., 2012) and brain volume, mostly the hippocampus 
and the amygdala (Erickson, Prakash, et al., 2010; Manna et al., 2015). BDNF is 
also involved in the pathogenesis of several neurological diseases such as 
Huntington’s disease (Ferrer, Goutan, Marin, Rey, & Ribalta, 2000; Zuccato & 
Cattaneo, 2007), Alzheimer’s disease (Ye, Tai, & Zhang, 2012) and Parkinson’s 
disease (Howells et al., 2000). Mature BDNF functions are related to several 
neuroplasticity mechanisms as neuronal protection and survival, axonal and 
dendritic remodeling, neuronal differentiation, synaptogenesis in axon 
terminals and synaptic transmission efficacy (Alsina, Vu, & Cohen-Cory, 2001; 
Barde, 1994; Knaepen, Goekint, Heyman, & Meeusen, 2010). The major source 
of circulating BDNF (70–80%) is the brain, mainly the cortex and hippocampus 
(Rasmussen et al., 2009). Commonly, serum and plasma levels of BDNF, which 
are highly correlated to BDNF in the CNS (Pan, Banks, Fasold, Bluth, & Kastin, 
1998), are reduced in MS patients compared to healthy controls (Azoulay et al., 
2005; Tongiorgi et al., 2012). However, during periods of higher inflammatory 
activity, especially after MS relapses (Frota et al., 2009),  BDNF levels rise 
(Weinstock-Guttman et al., 2007) being observed not only in plasma but also in 
immune and CNS cells of demyelinating lesions (Stadelmann et al., 2002). This 
transitory increase of BDNF associated to active stages of the disease is 
produced not only by neurons but also by immune cells (T lymphocyte, 
microglia and astrocytes) (Kerschensteiner et al., 1999), which has been 
interpreted as a neuroprotective mechanism in response to CNS injuries. The 
neuroprotective role of the BDNF in MS would also be supported by 
correlational results, which have showed that the greater the BDNF release is, 
the higher the white matter volume in MS patients is (Weinstock-Guttman et al., 
2007). Thus, a lower BDNF secreted by neuron and immune cells linked to the 
disease progression would indicate an exhaustion of the CNS restoration ability 
(Azoulay, Urshansky, & Karni, 2008; Azoulay et al., 2005).  
It is currently well recognized that exercise elicits molecular and cellular 
processes that promote neural plasticity in aging and disease (White & 
Castellano, 2008). Interestingly, among the potential pathways for CNS 
preservation, BDNF seems to be the most susceptible neurotrophin to be 
modulated by exercise (Knaepen et al., 2010). Commonly, BDNF circulating 
levels from several brain areas such as the hippocampus, amygdala, prefrontal 
and motor cortex, cerebellum, etc. (Fang et al., 2013; S. Gustafsson, Liang, & 
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Hilke, 2011; Koo et al., 2013; Liu et al., 2009; Marais, Stein, & Daniels, 2009; 
Neeper, Gomez-Pinilla, Choi, & Cotman, 1996) rise after a single bout of exercise 
(Ferris, Williams, & Shen, 2007; G. Gustafsson et al., 2009; Rojas Vega et al., 
2006) and they generally return back to baseline values in less than 1 h 
(Knaepen et al., 2010). As various meta-analyses have confirmed (Dinoff et al., 
2016; Szuhany, Bugatti, & Otto, 2015), exercise training programs chronically 
increase resting concentrations of BDNF in peripheral blood in healthy adults 
and, to higher extent, in individuals with neurological disorders as Parkinson’s 
disease (Hirsch, van Wegen, Newman, & Heyn, 2018). It must be noted that 
aerobic rather than resistance training programs seem to be more effective to 
increase resting BDNF concentrations in peripheral blood (Dinoff et al., 2016), 
but probably BDNF modulation depends on the type of exercise, number of 
muscles involved, intensity and duration of the exercise bouts as wells as the 
participants’ physical status. BDNF changes caused by regular exercise could 
explain why higher fitness levels and physical activity are associated with 
greater brain volume. Cross-sectional studies (Colcombe et al., 2003; Erickson 
et al., 2009; Floel et al., 2010; Verstynen et al., 2012) but more importantly 
longitudinal works (Erickson, Raji, et al., 2010) as well as randomized control 
trials (Colcombe et al., 2006; Erickson et al., 2011; Ruscheweyh et al., 2011) 
have shown how physical fitness and exercise are linked with brain volume and 
gray matter preservation in older adults (Erickson, Leckie, & Weinstein, 2014). 
Interestingly, as Erickson et al. (2011) showed, higher serum BDNF changes 
caused by an aerobic training program were correlated with changes in the 
hippocampal volume, which would confirm the neuroprotective role of BDNF as 
a physiological mediator of exercise effects on CNS preservation. It is important 
to note that a similar association has been found between physical fitness and 
white matter volumes, not only in older adults (Sexton et al., 2016), but also in 
children (Chaddock-Heyman et al., 2014).  
Based on these findings, recent works have tried to elucidate if exercise can 
work in a similar way in MS patients, helping to slow-down demyelination and 
axonal deterioration caused by the disease. To the best of the authors' 
knowledge, the first study which observed the link between exercise and MS 
progression was carried out by Prakash, Snook, Motl, and Kramer (2010). In 
this study, a significant relationship between aerobic fitness and both, gray 
matter volume and white matter integrity in RRMS patients was found. 
Subsequent cross-sectional studies have confirmed these results finding 
significant associations between the physical activity level and the volume of 
some brain areas (Klaren et al., 2015; Schwartz et al., 2016). These results, 
although promising, can be biased by confounding variables, especially the 
stage of the disease in which each patient is. Thus, longitudinal studies and 
randomized trials are needed to reduce the influence of confounding 
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parameters. To the best of the authors’ knowledge, only three intervention 
studies have analysed the effect of exercise programs on brain volume 
parameters in MS. The first one was a case study (Leavitt et al., 2014), in which 
an RRMS patient, who was involved in a 3-month aerobic training program, 
showed an important increase of the hippocampal volume (+16.5%), while 
another RRMS patient, who underwent a stretching program, did not show any 
noticeable change (+2.8%). Later, a very recent pilot study found a lower but 
non-significant (p < 0.1) brain atrophy in a group of RRMS patients who carried 
out a 6-month resistance training program compared with a control group 
(Kjolhede et al., 2018). Finally, the first randomized control trial analysing 
exercise and brain atrophy found that RRMS patients involved in a community-
located running training program presented an increase in brain volume 
compared with a control group; however, these changes were only significant 
in the pallidum (Feys et al., 2017).  
In spite of these promising results suggesting that exercise is not only 
helpful to reverse physical deconditioning associated to the MS disease but that 
it also has neuroprotective effects, from the authors’ point of view, it is too 
early to assert that exercise is able to reduce the brain atrophy caused by MS 
progression. It is even more difficult to perform any recommendations about 
which type of training would be the most appropriate to achieve this goal. Many 
more experimental studies with a larger sample size and longer training 
duration are needed to clarify all these questions. Until that happens, sport 
science professionals, exercise physiologists and physiotherapists should base 
their physical exercise interventions on the general recommendations and 
precautions developed for this population (Dalgas, Stenager, & Ingemann-
Hansen, 2008; Halabchi, Alizadeh, Sahraian, & Abolhasani, 2017), which ensure 
that exercise is well-tolerated and focuses on the improvement of the most 
prominent symptoms of each patient. 
 
CONCLUSIONS 
Overall, the results from the last decade presented in this overview suggest 
that physical exercise might be a complementary but powerful therapy to 
regulate the immune system behaviour in MS through the modulation of pro- 
and anti-inflammatory cytokine balance, as well as to promote neuroprotective 
and neurorestorative mechanisms through BDNF stimulation. Therefore, 
although exercise does not make the front pages of the main scientific journals 
as frequently as drug research does, these findings on exercise reinforce the 
idea that more randomized controlled trials, supervised by a multidisciplinary 
group (neurologists, practitioners, sport science professionals, etc.), should be 
carried out to confirm if exercise can play a neuroprotective role capable to 
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slow-down MS course, and to quantify their dose-response association in both, 
the relapse-remitting and the progressive forms of the disease. 
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